Conferences and Events

WIN Symposium

The VieCure team looks forward to attending the 10th anniversary edition of the WIN Symposium in Paris.  

The conference is held June 25-26, 2018 to explore the global implementation of precision oncology. 

Hosted by the WIN Consortium, the conference is a gathering of the most renowned scientists in the world focused on winning the war against cancer. 

The following themes will be covered in this year's program:

  • The challenges of building real cooperation to implement Precision Oncology Programs: A long and winding road
  • The next frontier of therapeutics in newly diagnosed patients: Standard of care or modern biomarker driven precision oncology?
  • Disruptive concepts and clinical trials shifting the paradigm of Precision Oncology
  • New concepts and therapeutics avenues in Precision Oncology
  • The regulatory challenges of a new model of drug development – The combination of targeted therapies
  • 10th year of the WIN Symposium in the era of Modern Oncology

Learn more and join us in Paris for this anniversary event.

Join experts from around the world at the MASCC/ISOO Annual Meeting, held June 28-30 in Vienna. 

The conference is dedicated to supportive care in cancer to improve the quality of cancer care worldwide. 

Trial by Fire: How to Action N-of-1 Clinical Trials for Cancer Patients

Trial by Fire: How to Action N-of-1 Clinical Trials for Cancer Patients

The availability of and correct interpretation of next-generation sequencing results gives the physician the information she or he needs to help the patient be an N-of-1 trial. Cognitive computing makes this decision possible at point-of-care; the physician can easily be made aware of the drivers, the potential targeted therapies and have the tools to apply, monitor and manage the patient throughout her or his treatment.

Factorial Complexity in Cancer Care is Here and Overwhelms!

Factorial Complexity in Cancer Care is Here and Overwhelms!

Genomics-based research is advancing at a pace that it is difficult for any cancer practitioner to interpret, absorb and action. The growing list of biomarker-driven care options compounds the already complex list of factors required for efficient and effective decisions to be made at point of care. Research in cancer care is at an all-time fever pitch. The Scopus database shows more than 1 million peer-reviewed publications and scientific proceedings on the topic of cancer research since 2008. How can any single physician or practice stay current, sift through and select from this vast library, and ultimately make safe sense of it for her/his patients?

Storm Warning: Old Ways Will Fail in Cancer Care

Storm Warning: Old Ways Will Fail in Cancer Care

Streamlining care with advanced decision support platform. By 2026, there will be ~26 million cancer survivors in America, and more than 2.1 million people who will be newly diagnosed with some form of cancer. Alarmingly, by this timeframe, about 25% of oncologists will be retiring and given current and projected enrollments in medical school, the replacement rate of oncologists will be only 13%.

Cognitive Computing Keeps Cancer Patients Out of the ER

Cognitive Computing Keeps Cancer Patients Out of the ER

Intelligent mobile app will improve communications between cancer patients and providers and reduce ER visits. Nonadherence to treatment plans is estimated to account for as much as 50 percent of treatment failures overall, and even for cancer patients, whose lives are on the line, adherence can be as low as 14 percent. Technology can help head-off these negative outcomes. Cancer patients become overwhelmed. The complexity and volume of daily medications and symptom monitoring, while they are experiencing life-altering emotional and physical changes, is the perfect setup for mistakes, oversights, stress and hopelessness. Intelligent mobile technology can break these daily tasks into bite-size pieces and deliver them at the right time, relieving a patient’s responsibility to constantly monitor all facets of their care. 

CMS decision transformative for cancer care

CMS decision transformative for cancer care

The Centers for Medicare & Medicaid Services’ (CMS) decision to reimburse for Next Generation Sequencing (NGS) for patients with advanced cancer is a major step to realizing personalized cancer treatment. This reimbursement approval fits perfectly with the expanding use of VieCure’s comprehensive platform for precision cancer care that optimally utilizes NGS within its proprietary VCureEyellation™ AI engine.   

Baptist Health to Improve Cancer Care with VCurePrecision™ Cognitive Computing Platform

Baptist Health to Improve Cancer Care with VCurePrecision™ Cognitive Computing Platform

VieCure and Baptist Health announced that the VCurePrecision cognitive computing platform, which allows clinicians to generate and manage comprehensive, personalized care plans in real time. The platform is supported by a proprietary inference engine with thousands of codified clinical rules in cancer care and will be deployed to advance care for patients of the largest provider of cancer services in central Alabama.

SURVIVEiT® Patient Tools

SURVIVEiT® Patient Tools

Our partners at SURVIVEiT® have developed patient tools that have been reviewed and approved as "best in class" by Team SURVIVEiT®'s medical and survivor advisory boards.

SURVIVEiT® is a global community of survivors, doctors, experts, and allies who provide hope, knowledge, and resources crucial to surviving cancer. 

Their Resource Library provides medical, financial, and support tools specific to each type of cancer.

SURVIVEiT® doesn't replace working with doctors, but rather augments their training with the practical experience of thousands of survivors who've successfully faced cancer.

After receiving a cancer diagnosis, the most important, urgent question to ask is, "What’s next?" SURVIVEiT® provides the answer.

Topics: